Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Goldencross Pharma Limited is an Indian pharmaceutical company and a wholly-owned subsidiary of Cipla Limited. Founded in 2000 and headquartered in Mumbai, the company specializes in the development and manufacture of active pharmaceutical ingredients (APIs) and a wide range of pharmaceutical formulations, including oral solids, liquids, and injectables. Goldencross operates significant manufacturing facilities in Sikkim, India, which are integral to Cipla's global supply chain for respiratory, anti-infective, and chronic disease therapies. The company supports Cipla's extensive pipeline of complex generics and has historically maintained its own R&D programs for bulk drugs and formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Golden Cross.